文献速递肺外科

欧洲胸外科医师学会数据库2019年报告:肺转移瘤切除术的当前手术实践与围手术期结局

Report from the European Society of Thoracic Surgeons database 2019: current surgical practice and perioperative outcomes of pulmonary metastasectomy.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

该研究基于欧洲胸外科医师学会数据库2007年7月至2019年7月的8868例肺转移瘤切除术患者数据,评估基线特征、手术方式和术后结局,并比较开放手术与VATS。结果显示VATS比例从2007年15%升至2018年58%,VATS组解剖性切除和淋巴结评估更少,但并发症率和住院时间更低。

要点

  • 肺转移瘤切除术中VATS应用从2007年15%增至2018年58%。
  • VATS组解剖性切除(24% vs 49%)和淋巴结评估(36% vs 70%)显著少于开放组。
  • VATS组并发症率9% vs 开放组18%,中位住院时间4天 vs 7天。

核心结论

  • 肺转移瘤切除术中VATS逐渐被接受,其解剖性切除和淋巴结评估比例低于开放手术,但并发症率和住院时间更短。

研究设计与样本

  • 基于欧洲胸外科医师学会数据库的回顾性分析,纳入2007年7月至2019年7月8868例肺转移瘤切除术患者。

主要发现

  • 开放胸廓切开术占63.5%(n=5627),VATS占36.5%(n=3241),中转率2.1%(n=69)。
  • 楔形或局部切除占61%(n=5425),解剖性切除占39%(n=3443),其中肺叶切除26%、肺段切除11%、双肺叶切除1%、全肺切除1%。
  • 淋巴结评估占58%(n=5097),包括采样21%和完全清扫37%。
  • 总体并发症率和死亡率分别为15%(n=1308)和0.8%(n=69),中位住院时间6天(IQR 4-8)。
  • VATS组解剖性切除24% vs 开放组49%,淋巴结评估36% vs 70%,并发症率9% vs 18%,中位住院时间4天 vs 7天,差异均显著(P < 0.001)。

临床怎么用

  • 肺转移瘤切除术中VATS应用增多,但需注意其解剖性切除和淋巴结评估比例较低,应结合患者选择合适术式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We report an overview of surgical practices and outcomes in patients undergoing pulmonary metastasectomy based on data from the European Society of Thoracic Surgeons database. METHODS: We retrieved data on resections performed for pulmonary metastases between July 2007 and July 2019. We evaluated baseline characteristics, surgical management and postoperative outcomes. Open and video-assisted thoracic surgery (VATS) procedures were compared in terms of surgical management, morbidity and mortality. RESULTS: We selected 8868 patients [male/female 5031/3837; median age: 64 years (interquartile range 55-71)] who underwent pulmonary metastasectomy. Surgical approach consisted of open thoracotomy in 63.5% of cases (n = 5627) and VATS in 36.5% (n = 3241), with a conversion rate of 2.1% (n = 69). Surgical resection was managed by wedge or local excision in 61% (n = 5425) of cases and anatomical resection in 39% (n = 3443); lobectomy: 26% (n = 2307); segmentectomy: 11% (n = 949); bilobectomy: 1% (n = 95); pneumonectomy: 1% (n = 92)). Lymph node assessment was realized in 58% (n = 5097) [sampling: 21% (n = 1832); complete dissection: 37% (n = 3265)]. Overall morbidity and mortality rates were 15% (n = 1308) and 0.8% (n = 69), respectively. Median duration of stay was 6 days (interquartile range 4-8). The rate of VATS procedures increased from 15% in 2007 to 58% in 2018. When comparing VATS and Open surgery, there were significantly (P < 0.001) fewer anatomical resections by VATS (24% vs 49%), lymph node assessments (36% vs 70%), less morbidity (9% vs 18%) and shorter durations of stay (median: 4 vs 7 days). CONCLUSIONS: We report a good overview of current surgical practices in terms of resection extent and postoperative outcomes with a gradual acceptance of VATS.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Gonzalez M, Brunelli A, Szanto Z, et al. Report from the European Society of Thoracic Surgeons database 2019: current surgical practice and perioperative outcomes of pulmonary metastasectomy. Eur J Cardiothorac Surg. 2021. PMID: 33230525. doi:10.1093/ejcts/ezaa405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。